Column Capital Advisors, LLC Tg Therapeutics, Inc. Transaction History

Column Capital Advisors, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 03, 2022	SELL	$7.81 - $20.45 $5,857 - $15,337	-750 Closed	0 $0
Q2 2020 Aug 12, 2020	SELL	$8.9 - $21.84 $3,328 - $8,168	-374 Reduced 33.27%	750 $14,000
Q1 2020 May 11, 2020	BUY	$7.14 - $15.99 $2,670 - $5,980	374 Added 49.87%	1,124 $11,000
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $3,824 - $8,400	750 New	750 $8,000

338

87.7M

2.35M

1.7M

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.68B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

Get notified when there are updates to the investment portfolio of Column Capital Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Column Capital Advisors, LLC with notifications on news.